Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

NOTE PAYABLE - Additional Information (Details)

v3.22.1
NOTE PAYABLE - Additional Information (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Jun. 03, 2020
Disclosure of detailed information about borrowings [line items]        
Receivable related to final milestone revenues from Medtronic $ 10      
Remaining note payable 175      
Reimbursement of legal and other transaction costs 1      
Other income 605  
Promissory Note with Medtronic [Member]        
Disclosure of detailed information about borrowings [line items]        
Amount borrowed       $ 15
Interest rate       8.00%
Amount capitalized to notes payable $ 605